Profile for BioMarin Pharmaceutical Inc. (BMRN)

$ 85.63   -1.96 (-2.24%) Volume: 1.11m 4:00 PM EST 23-Jan-2020
After Hours:  $ 85.57   -0.06 (-0.07%) Volume: 37.68k 5:10 PM EST 23-Jan-2020
Business Description:
Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.
Address: 770 Lindaro Street, San Rafael, CA, USA, 94901
Telephone: +1 415 506-6700 Website: http://www.bmrn.com
Facsimile: +1 415 382-7889 Email: [email protected]
Details
CEO: Jean-Jacques Bienaime
Employees: 2,849 Market Cap: 15.38b
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology, DJ US Biotechnology, Morningstar Developed Markets Americas PR USD, Morningstar Developed Markets PR USD, Morningstar Exponential Technologies PR USD, Morningstar Global Markets PR USD, Morningstar Narrow Moat PR USD, Morningstar US Defensive Super Sector PR USD, Morningstar US Growth PR USD, Morningstar US Healthcare Sector PR USD, Morningstar US Large-Mid Cap PR USD, Morningstar US Large-Mid Growth PR USD, Morningstar US Market Factor Tilt PR USD, Morningstar US Market PR USD, Morningstar US Mid Cap PR USD, Morningstar US Mid Growth PR USD, Morningstar US Small-Mid Cap PR USD, Morningstar US Small-Mid Growth PR USD, Morningstar US Target Market Exposure PR USD
Industry Classifications
Sector: Healthcare CIK: 1048477
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)